Cargando…
Pulsatile high-dose treatment with antiangiogenic tyrosine kinase inhibitors improves clinical antitumor activity
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer Netherlands
2017
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5511614/ https://www.ncbi.nlm.nih.gov/pubmed/28421290 http://dx.doi.org/10.1007/s10456-017-9555-8 |
| _version_ | 1783250368851869696 |
|---|---|
| author | Rovithi, Maria Verheul, Henk M. W. |
| author_facet | Rovithi, Maria Verheul, Henk M. W. |
| author_sort | Rovithi, Maria |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-5511614 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2017 |
| publisher | Springer Netherlands |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-55116142017-07-31 Pulsatile high-dose treatment with antiangiogenic tyrosine kinase inhibitors improves clinical antitumor activity Rovithi, Maria Verheul, Henk M. W. Angiogenesis Letter to the Editor Springer Netherlands 2017-04-18 2017 /pmc/articles/PMC5511614/ /pubmed/28421290 http://dx.doi.org/10.1007/s10456-017-9555-8 Text en © The Author(s) 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. |
| spellingShingle | Letter to the Editor Rovithi, Maria Verheul, Henk M. W. Pulsatile high-dose treatment with antiangiogenic tyrosine kinase inhibitors improves clinical antitumor activity |
| title | Pulsatile high-dose treatment with antiangiogenic tyrosine kinase inhibitors improves clinical antitumor activity |
| title_full | Pulsatile high-dose treatment with antiangiogenic tyrosine kinase inhibitors improves clinical antitumor activity |
| title_fullStr | Pulsatile high-dose treatment with antiangiogenic tyrosine kinase inhibitors improves clinical antitumor activity |
| title_full_unstemmed | Pulsatile high-dose treatment with antiangiogenic tyrosine kinase inhibitors improves clinical antitumor activity |
| title_short | Pulsatile high-dose treatment with antiangiogenic tyrosine kinase inhibitors improves clinical antitumor activity |
| title_sort | pulsatile high-dose treatment with antiangiogenic tyrosine kinase inhibitors improves clinical antitumor activity |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5511614/ https://www.ncbi.nlm.nih.gov/pubmed/28421290 http://dx.doi.org/10.1007/s10456-017-9555-8 |
| work_keys_str_mv | AT rovithimaria pulsatilehighdosetreatmentwithantiangiogenictyrosinekinaseinhibitorsimprovesclinicalantitumoractivity AT verheulhenkmw pulsatilehighdosetreatmentwithantiangiogenictyrosinekinaseinhibitorsimprovesclinicalantitumoractivity |